tnf inhibitors don't boost cancer risk in jia
Published 7 years ago • 367 plays • Length 4:25Download video MP4
Download video MP3
Similar videos
-
2:44
tnf inhibitors and juvenile idiopathic arthritis
-
2:26
anti-tnf treatment tied to reduced cv risk
-
3:00
tnf inhibitors limit ra progression
-
2:37
reducing anti-tnf dose possible in rheumatoid diseases
-
15:21
advances in efficacy and safety of tnf inhibitors -- ep. 18 of 32
-
4:17
a better herb for inflammation & joints? // spartan health 033
-
1:03:34
braf and tert promoter mutations in thyroid cancer with dr. mingzhao xing
-
23:36
revisiting anti-tnf 20 years later
-
1:48
breaking down udi, non viable, derivatives, and nanomaterials
-
5:20
researcher comment: tnf inhibitors linked to reduced vte risk in ra patients | anja strangfeld
-
0:19
understanding inflammatory arthritis in cancer patients caused by checkpoint inhibitors (:18)
-
1:09
emerging treatment options for refractory immune thrombocytopenia
-
7:06
tnf inhibitors and autoimmune disease
-
3:58
qd26 - breast cancer & a tnf inhibitor
-
0:41
recent advances in targeted therapies for tnbc
-
2:13
major breakthroughs in the field of bpdcn: combination therapies, managing cns involvement & more
-
20:22
consequences of tnf inhibition
-
10:42
tnf inhibitors rise to the top: drs. janet pope and david liew
-
16:59
advances in the efficacy and safety of tnf inhibitors - ep. 4